Fas is one of the most thoroughly evaluated ROCK inhibitors and has been demonstrated to provide a beneficial effect in the management of neurological disorders, including depression, stroke, and Alzheimer’s disease23,28. This evidence concerns the gene FAS and depressive symptom measurement.